These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 1348655

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia.
    Shi L, Ascher-Svanum H, Zhu B, Faries D, Montgomery W, Marder SR.
    Psychiatr Serv; 2007 Apr; 58(4):482-8. PubMed ID: 17412849
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Clinical experiences with depot neuroleptics].
    Peterová E, Baudis P, Dvoráková M, Vencovský E.
    Psychiatr Neurol Med Psychol Beih; 1975 Apr; 20-21():173-6. PubMed ID: 829618
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
    Smith RC, Vroulis G, Shvartsburd A, Allen R, Lewis N, Schoolar JC, Chojnacki M, Johnson R.
    Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
    [Abstract] [Full Text] [Related]

  • 31. Fluphenazine enanthate in the outpatient treatment of late paraphrenia.
    Raskind M, Alvarez C, Herlin S.
    J Am Geriatr Soc; 1979 Oct; 27(10):459-63. PubMed ID: 469146
    [Abstract] [Full Text] [Related]

  • 32. Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates.
    Douyon R, Angrist B, Peselow E, Cooper T, Rotrosen J.
    Am J Psychiatry; 1989 Feb; 146(2):231-4. PubMed ID: 2563211
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Rapid and megadose neuroleptic therapy. Critical review].
    de Girolamo G.
    Minerva Psichiatr; 1985 Feb; 26(4):323-6. PubMed ID: 2869395
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W.
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [Abstract] [Full Text] [Related]

  • 38. Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate.
    Marder SR, Aravagiri M, Wirshing WC, Wirshing DA, Lebell M, Mintz J.
    Schizophr Res; 2002 Jan 01; 53(1-2):25-30. PubMed ID: 11728835
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
    Walther S, Moggi F, Horn H, Moskvitin K, Abderhalden C, Maier N, Strik W, Müller TJ.
    J Clin Psychopharmacol; 2014 Feb 01; 34(1):124-8. PubMed ID: 24346752
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.